Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SUPRIYA Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
High and stable operating margin
Moderate revenue growth and above median growth of industry
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Moderate ROE but declining trend
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SUPRIYA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SUPRIYA Bulk, Block & Insider Trades
SUPRIYA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in the manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categor... Read More
Key personnel
Dr. Satish Waman WaghD
Executive Chairman of the Board
Mr. Krishna Raghunathan
Chief Financial Officer
Ms. Prachi Sathe
Company Secretary and Compliance Officer
Ms. Saloni Satish WaghD
Managing Director, Whole-Time Director
Ms. Shivani Satish WaghD
Joint Managing Director, Whole-Time Director
Mr. Balasaheb Gulabrao SawantD
Whole-Time Director
Ms. Smita Satish WaghD
Whole-Time Director
Mrs. Neelam Yashpal AroraD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Supriya Lifescience Ltd.?
The current share price of Supriya Lifescience Ltd. is ₹ 735.55 as of 09 Jan 2026.
What is the PE ratio of Supriya Lifescience Ltd.?
The Price-to-Earnings (PE) ratio of Supriya Lifescience Ltd. is 32.46 as of the latest financial data.
What is the ROE and ROCE of Supriya Lifescience Ltd.?
Supriya Lifescience Ltd. has a Return on Equity (ROE) of 10.19% and a Return on Capital Employed (ROCE) of 23.39% as per the latest financial reports.
What is the market cap of Supriya Lifescience Ltd.?
The market capitalization of Supriya Lifescience Ltd. stands at ₹ 5,919.93 Cr.
What is the dividend yield of Supriya Lifescience Ltd.?
The dividend yield of Supriya Lifescience Ltd. is 0.14% based on the current market price.
What is the RSI of Supriya Lifescience Ltd.?
The Relative Strength Index (RSI) of Supriya Lifescience Ltd. is 46.14.
What is the FII and DII holding in Supriya Lifescience Ltd.?
Foreign Institutional Investors (FII) hold 5.46% and Domestic Institutional Investors (DII) hold 3.04% of Supriya Lifescience Ltd. shares.
What sector does Supriya Lifescience Ltd. belong to?
Supriya Lifescience Ltd. operates in the Healthcare sector.
What is the beta of Supriya Lifescience Ltd. stock?
The beta of Supriya Lifescience Ltd. stock is 1.61, indicating its volatility relative to the broader market.
